Comac Medical is pleased to announce our participation in Biotech Showcase 2026, taking place on January 12–14, 2026, in San Francisco, USA. Held alongside the J.P. Morgan Healthcare Conference, Biotech Showcase is one of the industry’s leading investor and partnering events, bringing together global innovators, biotech leaders, and strategic investors.

Representing Comac Medical will be Chris Smyth, CEO, Christian Buhlmann, CCO, and Kelly Conti, Senior Business Development Director, who will be available throughout the event at Booth T-5. Our leadership team looks forward to engaging with biotechnology companies, investors, and industry partners to discuss collaboration opportunities and showcase Comac Medical’s comprehensive end-to-end clinical development capabilities.

The event’s agenda offers wide-ranging insights into emerging biotech trends, investment dynamics, and innovations shaping the future of clinical research – making it an ideal environment for fostering high-value partnerships.

At Comac Medical, we remain dedicated to advancing global clinical development through scientific excellence, operational expertise, and a commitment to delivering high-quality outcomes for our partners worldwide.

📍 Visit us at Booth T-5 or connect with us through the partnering platform to schedule a meeting with our executive team.

We look forward to meeting you in San Francisco!